TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
9/10/25 16:03 | 9/8/25 | PRPO | Precipio, Inc. | DE | Electr | LabEq | Laboratory Analytical Instrum | Laporte Kathleen | CT | D | S | -123 | 20.06 | 0 | -6 | -50 | 6 | D | |||||||||||||||
10/2/24 21:53 | 9/25/24 | CERO | Cero Therapeutics Holdings, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Laporte Kathleen | CA | D | M.d | 0 | 0.00 | 0 | 966 | 999% | 972 | I | |||||||||||||||
7/18/23 18:04 | 7/17/23 | ETNB | 89Bio, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Laporte Kathleen | CA | D | M.d | 33 | 2.64 | 0 | 13 | 0 | D | ||||||||||||||||
7/18/23 18:04 | 7/17/23 | ETNB | 89Bio, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Laporte Kathleen | CA | D | S.d | -235 | 18.80 | 0 | -13 | -100 | 0 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |